largely unstudied, but there is cause for concern given these findings. One of the many unfortunate lessons learned from the COVID-19 pandemic is that healthcare disparities in virtually every realm have been amplified; with the prompt transition to
Search Results
Thomas L. Sutton, Marina Affi Koprowski, Jeffrey A. Gold, Benjamin Liu, Alison Grossblatt-Wait, Caroline Macuiba, Andrea Lehman, Susan Hedlund, Flavio G. Rocha, Jonathan R. Brody, and Brett C. Sheppard
John Sweetenham
—for several decades, attention on racial disparities has been heightened in the past few years by 2 major events: COVID-19 pandemic’s disproportionate effect on minority populations, and the death of George Floyd. These events not only brought renewed focus
Juan P. Cata and Daniel D. Kim
. 10.2105/AJPH.2016.303061 26890165 2. Niles JK , Gudin J , Radcliff J , Kaufman HW . The opioid epidemic within the COVID-19 pandemic: drug testing in 2020 [published online October 8, 2020] . Popul Health Manag , doi: 10.1089/pop.2020
platform allows us to make vital cancer information more accessible than ever, as we adjust for the ongoing COVID-19 pandemic,” explained Robert W. Carlson, MD, Chief Executive Officer, NCCN. “We look forward to having attendees from around the world and
Noël Arring, Christopher R. Friese, Bidisha Ghosh, Marita Titler, Heidi Hamann, Sanja Percac-Lima, Adrian Sandra Dobs, Michelle J. Naughton, Pooja Mishra, Melissa A. Simon, Bingxin Chen, Electra D. Paskett, Robert J. Ploutz-Snyder, Martha Quinn, and Debra L. Barton
group of participants may or may not have coincided with the completion of an intervention for an individual participant. Data for 2020 were collected at the start of 2021. These data were impacted by the first year of the COVID-19 pandemic. In
and turnover is another area where asking the right question can go a long way. In a plenary session on Health System Recruitment and Retention Strategies, speakers pointed out how the aftermath of the COVID-19 pandemic has caused everyone to reassess
Network, Plymouth Meeting, PA; 7 University of Washington Medical Center, Seattle, WA Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction
The Cancer Center Cessation Initiative Implementation Science Working Group
treatment sustains during COVID-19, a global pandemic [published online August 18, 2021] . Cancer Epidemiol , doi: https://doi.org/10.1016/j.canep.2021.102005 34446379 13. Jose T , Ohde JW , Hays JT , Design and pilot implementation of
Presented by: Lillian R. Kreppel, Shivan J. Mehta, Mark H. Sawyer, Edward L. Trimble, Susan T. Vadaparampil, and moderated by Wui-Jin Koh
infrastructure for administering it, societal and parental resistance to the vaccine, and misinformation spread through social media. The COVID-19 pandemic has added another challenge by delaying all immunizations, Dr. Trimble reported. Finally, there are
Presented by: Natalie S. Callander
antibody therapy, Dr. Callander recommended changing either the PI, the IMiD, or both. Using an oral triplet regimen is another consideration during the COVID-19 pandemic in order to limit in-person visits. There are phase III data supporting the
